Solid Biosciences Inc.
SLDB
$9.54
-$0.39-3.93%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 377.68M | 380.68M | 187.85M | 236.14M | 268.11M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.93M | 2.98M | 2.42M | 3.11M | 3.30M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 14.50M | 13.13M | 15.19M | 5.60M | 7.24M |
| Total Current Assets | 395.11M | 396.79M | 205.46M | 244.85M | 278.64M |
|
|
|||||
| Total Current Assets | 395.11M | 396.79M | 205.46M | 244.85M | 278.64M |
| Net Property, Plant & Equipment | 24.63M | 25.21M | 26.09M | 26.89M | 27.45M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 846.00K | 891.00K | 991.00K | 2.17M | 2.20M |
| Total Assets | 420.58M | 422.89M | 232.54M | 273.91M | 308.29M |
|
|
|||||
| Total Accounts Payable | 4.36M | 5.56M | 3.22M | 8.43M | 4.70M |
| Total Accrued Expenses | 17.79M | 19.18M | 18.95M | 19.05M | 16.55M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.23M | 2.19M | 2.10M | 2.31M | 2.90M |
| Total Finance Division Other Current Liabilities | 4.20M | 3.35M | 9.20M | 6.55M | 5.70M |
| Total Other Current Liabilities | 4.20M | 3.35M | 9.20M | 6.55M | 5.70M |
| Total Current Liabilities | 28.58M | 30.28M | 33.47M | 36.34M | 29.85M |
|
|
|||||
| Total Current Liabilities | 28.58M | 30.28M | 33.47M | 36.34M | 29.85M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 17.92M | 18.48M | 19.06M | 19.62M | 20.16M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 46.51M | 48.76M | 52.53M | 55.97M | 50.00M |
|
|
|||||
| Common Stock & APIC | 1.44B | 1.39B | 1.14B | 1.13B | 1.12B |
| Retained Earnings | -1.07B | -1.01B | -957.78M | -907.99M | -862.21M |
| Treasury Stock & Other | -113.00K | -13.00K | 52.00K | 48.00K | -38.00K |
| Total Common Equity | 374.08M | 374.13M | 180.01M | 217.95M | 258.29M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 374.08M | 374.13M | 180.01M | 217.95M | 258.29M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 374.08M | 374.13M | 180.01M | 217.95M | 258.29M |
|
|
|||||